Clinical Trial Update: Ameparomo Capsules 250 mg Drug Use Investigation

View source ↗

Summary

A completed clinical trial investigating Ameparomo capsules (250 mg) for intestinal amebiasis; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Amebiasis

Drugs mentioned

• Ameparomo capsules 250 mg (Ameparomo)

Snippet

Sponsor: Pfizer | Conditions: Intestinal Amebiasis | Status: COMPLETED | Results posted: 2020-01-02